Coagulopathy in severe COVID-19 patients: causes, concerns and current treatment regimen
T Sengupta, A Luiz, C Suganthi… - Acta Haematologica …, 2024 - journals.viamedica.pl
Elevated D-dimer and fibrinogen level, mild thrombocytopenia, modest prolongation of
prothrombin time, and activated partial thromboplastin time, are key indicators of …
prothrombin time, and activated partial thromboplastin time, are key indicators of …
COVID-19-induced coagulopathy: Experience, achievements, prospects.
The presence of coagulopathy as part of the systemic inflammatory response syndrome is a
characteristic feature of severe coronavirus disease 2019 (COVID-19). Hematological …
characteristic feature of severe coronavirus disease 2019 (COVID-19). Hematological …
COVID-19-induced coagulopathy: Experience, achievements, prospects
The presence of coagulopathy as part of the systemic inflammatory response syndrome is a
characteristic feature of severe coronavirus disease 2019 (COVID-19). Hematological …
characteristic feature of severe coronavirus disease 2019 (COVID-19). Hematological …
[HTML][HTML] COVID coagulopathy and thrombosis: a systematic review
R Asrani, WF Bahou - 1, 2022 - touchoncology.com
Overview Introduction: Since the onset of the SARS-CoV-2 pandemic, haematological
laboratory abnormalities and thrombotic complications have been observed among infected …
laboratory abnormalities and thrombotic complications have been observed among infected …
[HTML][HTML] COVID-19, coagulopathy and venous thromboembolism: more questions than answers
M Marietta, V Coluccio, M Luppi - Internal and emergency medicine, 2020 - Springer
The acute respiratory illnesses caused by severe acquired respiratory syndrome corona
Virus-2 (SARS-CoV-2) is a global health emergency, involving more than 8.6 million people …
Virus-2 (SARS-CoV-2) is a global health emergency, involving more than 8.6 million people …
COVID-19-associated coagulopathy and immuno-thrombosis
D Celovska, M Wawruch, V Stvrtinova - Acta Phlebologica, 2021 - minervamedica.it
The global pandemic Coronavirus disease 2019 (COVID-19) is caused by a novel highly
virulent beta-coronavirus SARS-CoV-2. The infection SARS-CoV-2 is associated with a …
virulent beta-coronavirus SARS-CoV-2. The infection SARS-CoV-2 is associated with a …
COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation
Abstract COVID-19-associated coagulopathy (CAC) is a feature of COVID-19 that can lead
to various thrombotic complications and death. In this review, we briefly highlight possible …
to various thrombotic complications and death. In this review, we briefly highlight possible …
COVID-19 associated coagulopathy and thrombotic complications
ZT Mezalek, H Khibri, W Ammouri… - Clinical and Applied …, 2020 - journals.sagepub.com
The SARS-CoV-2 virus caused a global pandemic within weeks, causing hundreds of
thousands of people infected. Many patients with severe COVID-19 present with coagulation …
thousands of people infected. Many patients with severe COVID-19 present with coagulation …
Title: Covid-19-associated coagulopathy
COVID-19, primarily a respiratory disease, is considered a multi-systemic disease as
symptom severity increases. Blood coagulation abnormalities are key features of patients …
symptom severity increases. Blood coagulation abnormalities are key features of patients …
COVID-19 and coagulative axis: review of emerging aspects in a novel disease
M Boccia, L Aronne, B Celia, G Mazzeo… - … Archives for Chest …, 2020 - monaldi-archives.org
Latest evidences from literature suggest that SARS-CoV-2 disease 2019 (COVID-19) is
commonly complicated with coagulopathy and that disseminated intravascular coagulation …
commonly complicated with coagulopathy and that disseminated intravascular coagulation …